US FDA Searches For Consistency On Assessment Of Real-World Evidence

 
• By Derrick Gingery
  
Archery
The US FDA is employing a similar approach to ensure assessor consistency as it did with rare diseases.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards